GW Pharma appears poised to enter the United States cannabis market. The British company reportedly could get clearance from the U.S. Food and Drug Administration for a CBD-based product by early next year. The drug, called Epidiolex, previously received fast-track...
John Schroyer
John Schroyer's Latest Posts
Investors Not Exactly Stoked About New York’s MMJ Market
Companies spent millions of dollars combined trying to win one of New York's five coveted medical marijuana business licenses, but investors aren't exactly bullish on the market's potential now that permits have been awarded. Many institutional investors are concerned...
Unexpected Obstacles, Low Patient Count Lead to Medical Marijuana Price Hike in Minnesota
By John Schroyer With less than a month of sales under its belt, one of Minnesota's two licensed medical marijuana companies is making adjustments to cope with unexpected challenges that have cropped up. Minnesota Medical Solutions, also known as MinnMed, recently...
Eccentric Australian Entrepreneur Eyeing U.S. Cannabis Industry
A colorful and well-known former doctor from Australia may be making his professional debut in the United States cannabis industry sometime soon. Ex-physician Geoffrey Edelsten told the Daily Telegraph that he has a business partner in Canada who has already won a...
NY License Winner Had Banking Strategy
A company that won a license to grow and sell medical cannabis in New York expects to leverage its existing banking relationships in other states to obtain financial services for its new location. Columbia Care has "a number of banking partners to facilitate in-person...
New DEA Head: Marijuana ‘Probably’ Not as Bad as Heroin
If the newly installed chief of the Drug Enforcement Agency isn't an ally of marijuana, at least he's not a total prohibitionist. Acting Administrator Chuck Rosenberg, who took over for Michele Leonhart as head of the DEA in May, said this week that cannabis is...
Week in Review: CDC Weighs in on Edibles, High-Profile CA Raid + More Lawsuits on Horizon
By John Schroyer and Tony C. Dreibus
The Center for Disease Control issues what could prove to be an influential statement on marijuana edibles, a business run by a board member of California’s main cannabis industry association is raided, and lawsuit activity ramps up.
Florida Nursery to Challenge Tossed CBD Application
Even though Florida hasn't awarded its five CBD licenses to nurseries that applied earlier this month, it looks as though the state will face at least one administrative challenge. Two nurseries that filed applications after the July 8 deadline contend that officials...
First Nevada Dispensary Plans to Open Friday
By John Schroyer
After multiple delays, the first Nevada medical cannabis dispensary will open for business on Friday … unless there’s another unexpected setback, of course.
WA Prosecutor to Sue 15 Unlicensed Dispensaries
A group of unlicensed dispensaries that have resisted attempts to shut them down are now facing potential legal action. Dan Satterberg - the prosecutor for King County, which includes Seattle - said he plans to sue 15 dispensaries in unincorporated parts of the county...
New York Licensees to be Announced by Friday
The wait is nearly over. The New York Department of Health confirmed that it plans to reveal the winners of five state medical marijuana business licenses by Friday, according to the Daily Freeman News. It's a virtual certainty that legal...
Oregon Recreational Marijuana Sales to Begin Oct. 1
The third recreational cannabis state is now just months away from beginning sales. Oregon residents and visitors will be able to purchase legal adult-use marijuana as of Oct. 1, following the signing of a bill by Gov. Kate Brown that allows the state's existing...






